Tweak diet, supplement dose, or introduce targeted therapy if markers stay elevated
Many GLP-1 medications (Ozempic, Mounjaro) were first approved for diabetes treatment, then later approved for obesity under different brand names (Wegovy, Zepbound)
Systematic reviews and meta-analyses suggest modest benefits for glycaemic control and lipid profiles in people with type 2 diabetes or metabolic syndrome, but the overall quality of evidence is considered moderate at best
6 A 10-minute walk after dinner is a practical starting point that doesnt require special equipment
Its crucial for patients to understand that using expired semaglutide not only undermines treatment effectiveness but also increases exposure to harmful pathogens
My goal is to help patients understand their options clearly, feel medically supported, and pursue weight loss through an individualized plan not a one-size-fits-all program. Dr